Evaluating Daily Dosing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Evaluating Daily Dosing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Evaluating Daily Dosing Today - Breaking & Trending Today

FDA Accepts NDA for Vonoprazan (Voquenza) in Non-Erosive GERD

Published: December 7, 2023

The NDA submission was supported by positive data from the phase 3 PHALCON-NERD-301 study and has been assigned a standard 10-month review with a PDUFA target action date of July 19, 2024.

Source: hcplive.com

Related Topics:

Azmi NabulsiDrug AdministrationPhathom Pharmaceuticals Announces Positive ToplinePhathom PharmaceuticalsPhathom Pharmaceuticals AnnouncesPhathom Pharmaceuticals Announces VonoprazanPhathom PharmaceuticalPrescription Drug User Fee ActNew Drug ApplicationTablets New Drug ApplicationHeartburn AssociatedEvaluating Daily DosingNon Erosive GerdGastroesophageal Reflux DiseasePhalcon Nerd 301Phase 3